ID

27973

Description

NCT02499003 The GOAL Trial: Rescue Treatment With the Monoclonal Anti CD20-antibody Obinutuzumab (GA101) in Combination With Pixantrone for the Treatment of Patients With Relapsed Aggressive B-cell Lymphoma. Visit: End of Treatment. Quelle: Prof. Dr. med. Georg Heß Universitätsmedizin Mainz

Keywords

  1. 12/7/17 12/7/17 -
  2. 1/1/18 1/1/18 -
Copyright Holder

Prof. Dr. med. Georg Heß

Uploaded on

December 7, 2017

DOI

To request one please log in.

License

Creative Commons BY-NC 3.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :


No comments

In order to download data models you must be logged in. Please log in or register for free.

End of Treatment GOAL Trial B-cell Lymphoma NCT02499003

End of Treatment GOAL Trial B-cell Lymphoma NCT02499003

End of Treatment
Description

End of Treatment

Subject-ID
Description

Subject ID

Data type

text

Alias
UMLS CUI [1]
C2348585
Did the subject complete the treatment cycles?
Description

completion treatment cycles

Data type

boolean

If 'no', please specify reason(s) for early treatment termination: Progression of underlying disease
Description

Progression of underlying disease

Data type

boolean

If 'no', please specify reason(s) for early treatment termination: Adverse event
Description

Adverse event

Data type

boolean

If 'Adverse Event', please specify:
Description

Adverse event specification

Data type

text

If 'no', please specify reason(s) for early treatment termination: Death
Description

Death

Data type

boolean

If 'no', please specify reason(s) for early treatment termination: Withdrawal of consent
Description

Withdrawal of consent

Data type

boolean

If 'no', please specify reason(s) for early treatment termination: Non-compliance with protocol
Description

Non-compliance with protocol

Data type

boolean

If 'Non-compliance with protocol', please specify:
Description

Non-compliance with protocol specification

Data type

text

If 'no', please specify reason(s) for early treatment termination: Other
Description

Other reason early treatment termination

Data type

boolean

If 'Other', please specify:
Description

Other reason early termination specification

Data type

text

Similar models

End of Treatment GOAL Trial B-cell Lymphoma NCT02499003

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
End of Treatment
Subject ID
Item
Subject-ID
text
C2348585 (UMLS CUI [1])
completion treatment cycles
Item
Did the subject complete the treatment cycles?
boolean
Progression of underlying disease
Item
If 'no', please specify reason(s) for early treatment termination: Progression of underlying disease
boolean
Adverse event
Item
If 'no', please specify reason(s) for early treatment termination: Adverse event
boolean
Adverse event specification
Item
If 'Adverse Event', please specify:
text
Death
Item
If 'no', please specify reason(s) for early treatment termination: Death
boolean
Withdrawal of consent
Item
If 'no', please specify reason(s) for early treatment termination: Withdrawal of consent
boolean
Non-compliance with protocol
Item
If 'no', please specify reason(s) for early treatment termination: Non-compliance with protocol
boolean
Non-compliance with protocol specification
Item
If 'Non-compliance with protocol', please specify:
text
Other reason early treatment termination
Item
If 'no', please specify reason(s) for early treatment termination: Other
boolean
Other reason early termination specification
Item
If 'Other', please specify:
text

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial